Pharmacokinetics of nikkomycin Z after single rising oral doses

Antimicrobial Agents and Chemotherapy

Volumn 53, Issue 6, 2009, Pages 2517-2521

  Nix, David E ^a,f   Swezey, Robert R ^e   Hector, Richard ^d   Galgiani, John N ^a,b,c  

^a UNIVERSITY OF ARIZONA   (United States)

^b UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^c SOUTHERN ARIZONA VA HEALTH CARE SYSTEM   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e SRI INTERNATIONAL   (United States)

^f UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHITIN SYNTHASE; NIKKOMYCIN Z; PLACEBO;

ADULT; AREA UNDER THE CURVE; ARTICLE; COCCIDIOIDOMYCOSIS; DIZZINESS; DRUG BIOAVAILABILITY; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG DOSE ESCALATION; DRUG HALF LIFE; DRUG INDICATION; HEADACHE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; MALE; MAXIMUM PLASMA CONCENTRATION; NORMAL HUMAN; PRIORITY JOURNAL; SINGLE DRUG DOSE; TIME TO MAXIMUM PLASMA CONCENTRATION; VOLUNTEER;

ADMINISTRATION, ORAL; ADULT; AMINOGLYCOSIDES; ANTIBIOTICS, ANTIFUNGAL; AREA UNDER CURVE; HUMANS; MALE;

EID: 67049107844     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01609-08     Document Type: Article

References (12)

1. Antony, S. J., P. Jurczyk, and L. Brumble. 2006. Successful use of combination antifungal therapy in the treatment of coccidioides meningitis. J. Nat. Med. Assoc. 98:940-942.
2. Clemons, K. V., and D. A. Stevens. 1997. Efficacy of nikkomycin Z against experimental pulmonary blastomycosis. Antimicrob. Agents Chemother. 41:2026-2028.
3. Galgiani, J. N., N. M. Ampel, J. E. Blair, A. Catanzaro, R. H. Johnson, D. A. Stevens, and P. L. Williams. 2005. Coccidioidomycosis. Clin. Infect. Dis. 41:1217-1223.
4. Gaughran, J. P., M. H. Lai, D. R. Kirsch, and S. Silverman. 1994. Nikkomycin Z is a specific inhibitor of Saccharomyces cerevisiae chitin synthase isozyme Chs3 in vitro and in vivo. J. Bacteriol. 176:5857-5860. (Pubitemid 24280523)
5. Goldberg, J., P. Connolly, C. Schnizlein-Bick, M. Durkin, S. Kohler, M. Smedema, E. Brizendine, R. Hector, and J. Wheat. 2000. Comparison of nikkomycin Z with amphotericin B and itraconazole for treatment of histoplasmosis in a murine model. Antimicrob. Agents Chemother. 44:1624-1629.
6. Graybill, J. R., L. K. Najvar, R. Bocanegra, R. F. Hector, and M. F. Luther. 1998. Efficacy of nikkomycin Z in the treatment of murine histoplasmosis. Antimicrob. Agents Chemother. 42:2371-2374.
7. Hector, R. F., B. L. Zimmer, and D. Pappagianis. 1990. Evaluation of nikkomycins X and Z in murine models of coccidioidomycosis, histoplasmosis, and blastomycosis. Antimicrob. Agents Chemother. 34:587-593.
8. Herrin, K. V., A. Miranda, and D. Loebenberg. 2005. Posaconazole therapy for systemic coccidioidomycosis in a chimpanzee (Pan troglodytes): a case report. Mycoses 48:447-452.
9. Obi, K., J. Uda, K. Iwase, O. Sugimoto, H. Ebisu, and A. Matsuda. 2000. Novel nikkomycin analogues: inhibitors of the fungal cell wall biosynthesis enzyme chitin synthase. Bioorg. Med. Chem. Lett. 10:1451-1454.
10. Ramani, R., and V. Chaturvedi. 2007. Antifungal susceptibility profiles of Coccidioides immitis and Coccidioides posadasii from endemic and non-endemic areas. Mycopathalogia 163:315-319. (Pubitemid 46919105)
11. Ruiz-Herrera, J., and G. San-Blas. 2003. Chitin synthesis as a target for antifungal drugs. Curr. Drug Targets Infect. Disord. 3:77-91.
12. Smith, B. P., F. R. Vandenhende, K. A. DeSante, N. A. Farid, P. A. Welch, P. T. Calloghan, and S. T. Forgue. 2000. Confidence interval criteria for assessment of dose proportionality. Pharm. Res. 17:1278-1283.